Fortress BiotechvsMerck & Company

FBIO and MRK stock compared: price, dividend, valuation and results, from SEC filings.

FBIO

Fortress Biotech, Inc.

$1.71

Value $54M

-9.04%
FBIO's page

MRK

Merck & Company, Inc.

$144.46

Value $357B

-2.23%
MRK's page

Fortress Biotech (FBIO) has a market value of $54M and Merck & Company (MRK) $357B. Over the last year, with dividends, FBIO moved -34.7% and MRK +60.0%. Dividend yield: FBIO none, MRK 2.35%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    FBIO$54M

    MRK$357B

    MRK is 6,659 times FBIO

  • Revenue, 12 months

    FBIO$70M

    MRK$67.4B

    MRK is 963 times FBIO

  • Net income, 12 months

    FBIO$100M

    MRK$2.5B

    MRK is 24 times FBIO

  • Operating margin

    FBIO-42.2%

    MRK–

  • ROIC

    FBIO-14.7%

    MRK3.9%

    18.6 points apart

  • P/E

    FBIO–

    MRK145.6

  • Dividend yield

    FBIO0.0%

    MRK2.4%

    2.4 points apart

  • 5-year return

    FBIO-96.6%

    MRK+101.1%

    197.7 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

FBIO-96.6%

MRK+101.1%

010020020222023202420252026
Returns by period
PeriodFBIOWith dividendsMRKWith dividends
1 year since November 14, 2025-34.7%Price -34.7%+60.0%Price +55.5%
3 years since November 16, 2023+19.6%+6.1% a yearPrice +19.6%+55.2%+15.8% a yearPrice +41.6%
5 years since November 15, 2021-96.6%-49.2% a yearPrice -96.6%+101.1%+15.0% a yearPrice +72.6%
10 years since November 16, 2016-95.4%-26.6% a yearPrice -95.4%+228.0%+12.6% a yearPrice +141.7%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

FBIOFortress BiotechMRKMerck & Company

Valuation

FBIOMRK
Valuation
Price$1.71$144.46
Market value$54M$357B
Enterprise value (EV)–$401B
P/E–145.6
P/E, 5-year median–14.8
P/B0.38.0
EV/EBIT–84.3
Free cash flow yield–4.1%

Results and growth

FBIOMRK
Results and growth
Revenue, 12 months$70M$67.4B
Net income, 12 months$100M$2.5B
Free cash flow, 12 months$126M$14.7B
Earnings per share, 12 months$2.30$0.98
Revenue growth, year on year9.7%1.3%
Revenue growth a year, past+6.8%over 5 years+9.4%over 5 years
EPS growth a year, past–+21.2%over 5 years

Margins and returns on capital

FBIOMRK
Margins and returns on capital
Gross margin66.2%71.8%
Operating margin-42.2%–
Net margin143.1%3.6%
ROIC-14.7%3.9%
ROE84.6%5.2%

Balance sheet

FBIOMRK
Balance sheet
Cash$152M$9.7B
Total debt–$53.8B
Net debt / EBITDA–5.7
Interest cover-3.2×2.4×

Dividends and buybacks

FBIOMRK
Dividends and buybacks
Dividend yield–2.4%
Dividend per share, 12 months–$3.40
Dividend growth a year, past–+5.8%over 5 years
Buyback yield–1.4%
Shareholder yield–3.8%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: FBIO or MRK

Didn't find what you were looking for?

Ask us
Which is bigger, Fortress Biotech or Merck & Company?

By market value, Merck & Company ($357B) is about 6,659.4 times Fortress Biotech ($54M), at today's prices.

How did FBIO and MRK stock do over the last 10 years?

Since November 16, 2016, FBIO's price moved -95.4% and MRK's +141.7%. With dividends: FBIO -95.4% (-26.6% a year), MRK +228.0% (+12.6% a year). Past returns do not predict future ones.

Which pays the higher dividend, FBIO or MRK?

The dividend yield at today's price is none for Fortress Biotech and 2.35% for Merck & Company. Over the last twelve months they paid – and $3.40 per share.

Which has the higher profit margins, Fortress Biotech or Merck & Company?

Over the last twelve months, the net margin was 143.1% for Fortress Biotech and 3.6% for Merck & Company, and the operating margin -42.2% and –. Revenue was $70M and $67.4B.

Which is the better investment, Fortress Biotech or Merck & Company?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.